Lipid changes within the epidermis of living skin equivalents observed across a time-course by MALDI-MS imaging and profiling

Lipids in Health and Disease

Volumn 14, Issue 1, 2015, Pages

  Mitchell, Christopher A ^a   Long, Heather ^b   Donaldson, Michael ^b   Francese, Simona ^a   Clench, Malcolm R ^a  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Lipids; Living skin equivalents; MALDI; MALDI MSI; Mass spectrometry imaging; MSI

Indexed keywords

LIPID; PHOSPHATIDYLCHOLINE; SPHINGOMYELIN;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; EPIDERMIS; HUMAN; HUMAN TISSUE; IMAGE QUALITY; IMAGING AND DISPLAY; INCUBATION TIME; LIPID ANALYSIS; LIPID COMPOSITION; LIPID METABOLISM; LIVING SKIN EQUIVALENT; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION MASS SPECTROMETRY IMAGING; MEASUREMENT ACCURACY; SKIN; TANDEM MASS SPECTROMETRY; TISSUE SECTION; TREATMENT RESPONSE; ARTIFICIAL SKIN; CHEMISTRY; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; MULTIVARIATE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES; THREE DIMENSIONAL IMAGING; TIME FACTOR;

EPIDERMIS; HUMANS; IMAGING, THREE-DIMENSIONAL; LIPIDS; MULTIVARIATE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; SKIN, ARTIFICIAL; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPHINGOMYELINS; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 84938582109     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/s12944-015-0089-z     Document Type: Article

References (20)

1. El Ghalbzouri A, Siamari R, Willemze R, Ponec M. Leiden reconstructed human epidermal model as a tool for the evaluation of the skin corrosion and irritation potential according to the ECVAM guidelines. Toxicol In Vitro. 2008;22:1311-20.
2. Bouwstra JA, Ponec M. The skin barrier in healthy and diseased state. BBA - Biomembranes. 1758;2006:2080-95.
3. Sonnino S, Prinetti A, Mauri L, Chigorno V, Tettamanti G, Tettamanti G. Dynamic and structural properties of sphingolipids as driving forces for the formation of membrane domains. Chem Rev. 2006;106:2111-25.
4. Motta M, Molta S, Caretti A, Sesana S, Ghidoni R. Ceramides of the psoriatic scale: Fatty acids composition. J Invest Dermatol. 1996;107:97.
5. Caprioli RM, Farmer TB, Gile J. Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal Chem. 1997;69:4751-60.
6. Roy S, Touboul D, Brunelle A, Germain DP, Prognon P, Laprevote O, et al. Imaging mass spectrometry: a new tool for the analysis of skin biopsy. Application in Fabry's disease. Ann Pharm Fr. 2006;64:328-34.
7. Bunch J, Clench MR, Richards DS. Determination of pharmaceutical compounds in skin by imaging matrix-assisted laser desorption/ionisation mass spectrometry. Rapid Commun Mass Spectrom. 2004;18:3051-60.
8. Marshall P, Toteu-Djomte V, Bareille P, Perry H, Brown G, Baumert M, et al. Correlation of skin blanching and percutaneous absorption for glucocorticoid receptor agonists by matrix-assisted laser desorption ionization mass spectrometry imaging and liquid extraction surface analysis with nanoelectrospray ionization mass spectrometry. Anal Chem. 2010;82:7787-94.
9. Prideaux B, Atkinson S, Carolan V, Morton J, Clench M. Sample preparation and data interpretation procedures for the examination of xenobiotic compounds in skin by indirect imaging MALDI-MS. Int J Mass Spectrom. 2007;206:243-51.
10. Hart PJ, Francese S, Claude E, Woodroofe MN, Clench MR. MALDI-MS imaging of lipids in ex vivo human skin. Anal Bioanal Chem. 2011;401:115-25.
11. Enthaler B, Pruns JK, Wessel S, Rapp C, Fischer M, Wittern K. Improved sample preparation for MALDI-MSI of endogenous compounds in skin tissue sections and mapping of exogenous active compounds subsequent to ex-vivo skin penetration. Anal Bioanal Chem. 2012;402:1159-67.
12. Avery JL, McEwen A, Flinders B, Francese S, Clench MR. Matrix-assisted laser desorption mass spectrometry imaging for the examination of imipramine absorption by Straticell-RHE-EPI/001 an artificial model of the human epidermis. Xenobiotica. 2011;41:735-42.
13. Thakoersing VS, Danso MO, Mulder A, El Ghalbzouri A, Bouwstra JA. Nature versus nurture: does human skin maintain its stratum corneum lipid properties in vitro? Exp Dermatol. 2012;21:865-70.
14. Thakoersing VS, van Smeden J, Mulder AA, Vreeken RJ, El Ghalbzouri A, Bouwstra JA. Increase presence of monounsaturated fatty acids in the stratum corneum of human skin. J Invest Dermato. 2014;133:59-67.
15. Merrill Jr AH, Schmelz EM, Dillehay DL, Spiegel S, Shayman JA, Schroeder JJ, et al. (1997) Sphingolipids - the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol. 1997;142:208-25.
16. Yang J, Yu Y, Sun S, Duerksen-Hughes PJ. Ceramide and other sphingolipids in cellular responses. Cell Biochem Biophys. 2004;40:323-50.
17. Sato J, Denda M, Nakanishi J, Nomura J, Koyama J. Cholesterol sulphate inhibits proteases that are involved in desquamation of stratum corneum. J Invest Dermatol. 1999;111:189-93.
18. Bouwstra JA, Gooris GS, Dubbelaar FE, Ponec M. Cholesterol sulfate and calcium affect stratum corneum lipid organization over a wide temperature range. J Lipid Res. 1999;40:2303-12.
19. Gray GM, Yardley HJ. Different populations of pig epidermal cells: isolation and lipid composition. J Lipid Res. 1975;16:441.
20. Ponec M, Boelsma E, Weerheim A, Mulder A, Bouwstra J, Mommaas M. Lipid and ultrastructural characterization of reconstructed skin models. Int J Pharm. 2000;203:211-25.